A new study by Christian Medical College (CMC) Vellore has suggested that mixing vaccines for COVID-19 shows a mixed result depending on the initial vaccination schedule, presenting programmatic challenges moving forward. The government, in light of this newfound data, has suggested that they may not allow booster doses of COVID-19 vaccines other than the one […]
Covaxin
Paediatric trials for Covaxin underway
India has commenced paediatric trials for Covaxin, its indigenously-manufactured vaccine against COVID-19. Covaxin, manufactured by Hyderabad-based firm Bharat Biotech, is one of four vaccines authorised for use in India alongside Covishield (produced by the Serum Institute of India on license from AstraZeneca), the Russian-manufactured Sputnik-V, and the Moderna vaccine. Bharat Biotech announced last month that […]
Covaxin to face WHO scrutiny this week
India’s homegrown COVID-19 vaccine Covaxin is to face scrutiny from the World Health Organization (WHO) on June 23rd when a pre-submission hearing will be held. Manufacturer Bharat Biotech received the WHO’s nod for its expression of interest for emergency use listing of Covaxin, in a step commentators regard as moving the vaccine closer to securing […]
Covaxin shows promising results in trials
Covaxin, India’s homegrown COVID-19 vaccine candidate, has shown promising results in interim phase-III trials. The vaccine, manufactured by Hyderabad, Telangana-headquartered firm Bharat Biotech, demonstrated an almost 81 percent interim clinical efficacy according to the company following the release of results from the interim phase-III trials on Wednesday. “Covaxin demonstrates high clinical efficacy trend against COVID-19 […]